The cell surface markers detection market involves the detection and identification of biomarkers present on the surface of cells. These markers play a pivotal role in cancer diagnostics and treatment, enabling early diagnosis, disease staging, and monitoring disease progression or treatment response. The rising global prevalence of chronic diseases such as cancer is a key driver for the market. Cancer cell surface markers help determine the type and stage of cancer along with enabling targeted therapy selection. Cell surface markers also aid in stem cell research and development of regenerative medicine.
The global cell surface markers detection market is estimated to be valued at US$ 5,459.5 million in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period of 2023 to 2030.
Key Takeaways
Key players operating in the cell surface markers detection market are Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), and Danaher Corporation (Beckman Coulter Inc.). These players are focusing on new product launches and vertical integration strategies to gain maximum market share.
The rising global cancer burden presents lucrative opportunities for market players to develop advanced diagnostics and targeted therapeutics. Emerging economies in Asia Pacific and Latin America with growing healthcare expenditure also provide opportunities for market expansion.
Key players are expanding their presence globally through partnerships, acquisitions, and distribution agreements. For instance, BD acquired Immucor to expand its transfusion diagnostics business globally. Thermo Fisher aims to enter new markets in Asia Pacific and Latin America through collaborations.
Market Drivers
Increasing Cancer Incidence: The global cancer burden has been rising consistently. As per WHO estimates, cancer cases are expected to rise by over 70% in the next two decades. Cell surface markers play a critical role in cancer screening, diagnosis, and targeted treatment selection, driving demand.
Advancements in Diagnostic Technologies: Technological advancements are enabling development of high-throughput, automated, and rapid cell surface marker detection systems.
Market Restraints
High Capital Requirements: Establishment of cell analysis laboratories requires substantial capital investments for equipment, reagents, and infrastructure. This poses challenges, especially for small labs and those in developing regions.
Lack of Skilled Professionals: Operation and interpretation of advanced cell analysis tools require highly trained technicians and pathologists. Shortage of skilled workforce presents a barrier, restricting market potential in some regions.
Segment Analysis
The cell surface markers detection market is segmented into instruments/analyzers, reagents consumables, and services. The reagents consumables segment dominated the market in 2023 due to the repeat purchase nature and frequent consumable requirement of reagents in cell surface markers detection procedures. The instruments/analyzers segment is anticipated to register the highest CAGR during the forecast period.
Global Analysis
North America dominated the global cell surface markers detection market in 2023 and is anticipated to maintain its dominance during the forecast period. Presence of advanced healthcare infrastructure and high healthcare expenditure are primary factors driving the market in this region. Asia Pacific is projected to be the fastest growing regional market during the forecast period due to increasing healthcare spending in rapidly developing countries of China and India, high disease burden and growing awareness regarding cell surface markers detection procedures in the region. Regional governments have initiated many programs to enhance healthcare access in rural and underdeveloped areas, which is further expected to boost market growth.
